In addition to the glucocorticoids, the glucocorticoid receptor (GR) is regulated by post-translational modifications, including SUMOylation. We have analyzed how SUMOylation influences the activity of endogenous GR target genes and the receptor chromatin binding by using isogenic HEK293 cells
INTRODUCTION
Glucocorticoid receptor (GR) is a hormone-controlled transcription factor belonging to the nuclear receptor superfamily (1) . The GR is activated by natural and synthetic glucocorticoids that are among the most widely prescribed pharmaceuticals worldwide because of their anti-inflammatory effects (2) . On binding of the ligand, the GR moves to nucleus and binds with high affinity to short DNA-sequences, glucocorticoid response elements (GREs) on chromatin where it influences transcription by recruiting various coregulators including chromatinremodeling complexes (1, (3) (4) (5) . The anti-inflammatory effect of GR has been thought to be largely due to its capability to inhibit the action of activator protein 1 (AP-1) and nuclear factor-kB (NF-kB) by directly interacting with them or indirectly e.g. by inducing the expression of NFKBIA gene that encodes the NF-kB inhibitor IkBa (6) (7) (8) . The GR is also capable of inducing apoptosis (9) and cell cycle arrest (10) of certain cell types by affecting to the expression of genes such as Bcl-2, NFKBIA and cyclin-dependent protein kinase inhibitors (CDKN).
In addition to the glucocorticoids, post-translational modifications, such as phosphorylation and SUMOylation, regulate the activity of GR (11) (12) (13) (14) . In SUMOylation, small ubiquitin-related modifier proteins (SUMOs) are covalently conjugated to specific lysine residues of target proteins. The major group of SUMO targets resides in the nucleus and it includes several nuclear receptors (15) . Humans express three SUMO proteins, SUMO-1, -2 and -3, that can form isopeptide linkages with specific lysine residues of target proteins. SUMO-2 and -3 are practically identical (from herein called SUMO-2/3), but SUMO-1 is only $50% identical with SUMO-2/3 (16, 17) . The SUMOylation pathway is similar to that of ubiquitylation pathway, but the E1, E2 and E3 enzymes are specific for the SUMOylation (18, 19) .
Activation of SUMOs occurs through SAE1 and -2 dimer (E1) and UBC9 (E2) conjugates SUMOs to target proteins (20) . SUMO modifications are highly dynamic and shown to be reversed (deSUMOylated) by a family of SUMOspecific proteases (SENP1, -2, -3, -5, -6 and -7) (21, 22) . The essential nature of SUMOylation for mammalian development is demonstrated by the Ubc9 knockout mice that show embryonic lethality (23) .
Interestingly, UBC9, protein inhibitor of activated STAT (PIAS) proteins (SUMO E3 ligases) and SENP1 and -2 can function as coregulators for steroid receptors (19, 24) . SUMO modifications of transcription factors have been often linked to transcriptional repression (15) . However, these notions are mainly based on the usage of ectopically expressed transcription factors and reporter genes. The repression has been suggested to be due to association of SUMOylated transcription factors with SUMO-binding corepressors, such as DAXX (death domain-associated protein) (25, 26) . However, accumulating evidence implies that the SUMOylation does not merely repress transcription factor activity. For example, intact SUMOylation sites of androgen receptor (AR) are needed for the receptor's full transcriptional activity on many target genes (27) .
We and others have previously shown that the SUMO conjugation sites in the GR act as synergy control motifs restricting the transcriptional activity of the receptor on a minimal promoter driven by two or more GREs, but not on a more complex natural mouse mammary tumor virus promoter (11, 28) . There may also be cross-talk between the GR SUMOylation and the receptor phosphorylation by cJun N-terminal kinase in the regulation of glucocorticoid signaling (14) . Furthermore, the inhibitory effect of SUMOylated GR is not dependent on the SUMO-binding protein DAXX, but on some other factor that is preferentially recruited on promoters with multiple GREs (29) . However, there is scarce information about the role of SUMOylation in the regulation of endogenous GR target genes. Here, we have investigated in an unbiased fashion how GR SUMOylation influences the GR activity in a natural chromatin environment by using genome-wide methods. To that end, we used isogenic cell lines stably expressing either wild-type GR (wtGR) or SUMOylation-site mutated GR (GR3KR) using human embryonal kidney (HEK293) cells that contain low (nonfunctional) levels of GR and have been previously found useful for studying GR signaling (30) . Our transcriptome and cistrome analyses reveal for the first time that the GR SUMOylation sites regulate the receptor's chromatin occupancy and function in a target locus-selective fashion and that the genes differently expressed by glucocorticoid due to the GR SUMOylation sites are significantly enriched in cell proliferation and apoptosis pathways. In addition, our ChIP-seq data reveal that a significant portion of chromatin-bound SUMO-2/3 overlaps with the GR cistrome in the HEK293 cells.
MATERIALS AND METHODS

Plasmid constructions
For generation of pcDNA5/FRT-hGR, pcDNA5/FRThGR3KR, pcDNA3.1-hGR and pcDNA3.1-hGR3KR, complementary DNAs (cDNAs) from pSG5-hGR and pSG5-hGR-K277,293,703R (11) were transferred as BamHI fragments into pcDNA5/FRT or pcDNA3.1(+) (Invitrogen) backbone. The plasmids described were verified by sequencing.
Cell culture
Stably GR expressing isogenic HEK293 (Flp-In TM -293, Invitrogen) cells lines were generated according to manufacturer's instructions and as described (27) . Flp-In TM -293 cells grown on 10-cm dishes were cotransfected with 9:1 ratio of pOG44:pcDNA5/FRT-hGR or pcDNA5/FRThGR-3KR using Lipofectamine 2000 (Invitrogen). Fortyeight hours after transfection, the cells were divided 1:2 and hygromycin-B (100 mg/ml) (Invitrogen) was added. Thereafter, cells received fresh hygromycin-supplemented medium every 3 days and were grown for 19 days. Twelve hygromycin-resistant foci were picked in each culture with pipette tips and transferred to 24-well plate wells, grown for 8 days and transferred to 12 wells for further growth and analyses. These wells were divided to four portions for Zeocin TM (Invitrogen) sensitivity test, b-galactosidase assay, GR expression analyses and further growth. Three equivalent clones of both GR forms were further analyzed for expression of endogenous GR target genes, and one representative clone was chosen for further experiments. The stably GR-expressing HEK293 cell lines were maintained in Dulbecco's modified Eagle's medium (Gibco Õ , Invitrogen) supplemented with 10% (v/v) fetal bovine serum, 25 U/ml penicillin and 25 mg/ml streptomycin and 100 mg/ml hygromycin-B. U2 osteosarcoma (U2Os) cells [American Type Culture Collection (ATCC)] were transfected with 15 mg of pcDNA3.1-hGR or pcDNA3.1-hGR-K277,293,703R using TransIT-LT1 (Mirus Bio Corporation) transfection reagent. Forty-eight hours after transfection, the cells were split to 1:2 and geneticin (400 mg/ ml) was added. Medium containing geneticin was replaced every third day. Two weeks after transfection, the cells were split to RNA and western blot analyses and further growth. Based on these analyses, one representative clone for both GR forms was picked for further experiments. The stably GR-expressing U2Os cell lines were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 1 mM Na-puryvate, 25 U/ml penicillin and 25 mg/ml streptomycin and 400 mg/ml geneticin.
Antibodies
Anti-GR (sc-1003) and normal rabbit IgG (sc-2027) were from Santa Cruz Biotechnology, anti-SUMO-1 (33-2400) was from Invitrogen Life Technologies and anti-SUMO-2/3 (M114-3) was from MBL International Corporation.
Cell proliferation assay
For proliferation assays, both empty HEK293 (Flp-In TM -293 cells, background), wtGR-and GR3KR-expressing HEK293 cells were seeded onto 96-well plates (5000 cells/well). Cells were grown for 48 h before addition of 100 nM dexamethasone (dex). At indicated time points, six parallel samples of the cells were analyzed by using Cell Titer96 Aqueous cell proliferation assay reagent (Promega) according to manufacturer's instructions. The quantity of formazan reaction product as measured by the absorbance at 492 nm is directly proportional to the number of metabolically active living cells in culture.
Fluorescence-activated cell sorting
For cell cycle analysis, HEK293 cells were seeded on 12-well plates and grown ± dex and after 48 h, cells were trypsinized, suspensed into phosphate-buffered saline (PBS) and fixed in ice cold 70% ethanol. After overnight incubation at 4 C, cells were centrifuged, resuspensed into PBS containing 150 mg/ml RNase A (Fermentas) and incubated for 1 h at 50 C. To stain DNA, 8 mg/ml final concentration of propidium jodide was added to the samples and incubated for 2 h at 37 C in dark. Measurements of DNA contents of triplicate samples were performed with fluorescence-activated cell sorting (FACS) Canto II flow cytometer using BD FACS Diva Flow Cytometer Software (Becton Dickinson).
Isolation of RNA and RT-qPCR analyses
Stably GR-expressing HEK293 and U2Os cells were seeded onto 6-well plates (300 000 and 250 000 cells/well, respectively) and grown 36 h in steroid-depleted transfection medium. Subsequently, cells were treated either with vehicle (ethanol, 0.01%) or 100 nM of dex for 6 h. Total RNA was extracted using TriPure (Roche) and converted to cDNA using Transcriptor First Strand cDNA synthesis Kit (Roche Diagnostics GmbH, Mannheim, Germany) according to manufacturer's instructions. cDNA was used as a template in RT-qPCR, which was carried out using LightCycler Õ 480 SYBR Green I Master (Roche Diagnostics GmbH) and LightCycler Õ 480 System (Roche) and with specific primers listed in Supplementary Table S1 . Analyzed RPL13A messenger RNA levels were used to normalize the amounts of total RNA between the samples. Fold changes were calculated using the formula 2
, where ÁÁCt is ÁCt (dex) -ÁCt (EtOH) , ÁCt is Ct (gene X) -Ct (RPL13A) and Ct is the cycle at which the threshold is crossed.
Microarray analysis
Total RNA was analyzed on Sentrix HumanHT-12 v4 Expression BeadChips (Illumina) using the manufacturer's protocol at the Finnish Microarray and Sequencing Center (Turku, Finland). Microarray data were analyzed within R software version 2.13.0. (http:// www.r-project.org/) using the Bioconductor package lumi [(31), http://www.bioconductor.org/] and normalized using VST transformation and RSN normalization used as standard approach for Illumina arrays. Differentially expressed genes were analyzed with limma package, with linear model fitting for statistical analyses by empirical Bayes method. The P-values were adjusted with the Benjamini and Hochberg method to control the false discovery rate (FDR). Biological comparisons were made, for example dex/vehicle GR3KR or dex/vehicle wtGR and dex/vehicle GR3KR versus dex/vehicle wtGR. Heat maps were generated by using heatmap.2 in the R package gplots. Unsupervised hierarchical clustering of genes was performed using Euclidean distance and complete linkage. Ingenuity Pathway Analysis Õ (IPA) was used to identify biological processes differently enriched between wtGRand GR3KR-expressing cells.
ChIP and DNA deep sequencing
Stably GR-expressing cells were seeded at $70% confluence onto 175 cm 2 bottles and allowed to grow in steroiddepleted transfection medium for 72 h prior ChIP. Cells were treated either with vehicle or 100 nM of dex for 1 h. The cells were cross-linked by adding formaldehyde to the medium to a final concentration of 1% (v/v) for 10 min at C. The beads were harvested by magnets and washed five times for 3 min in cold room by rotation with 1 ml of LiCl IP wash buffer [100 mM Tris (pH 7.5), 500 mM LiCl, 1% (w/v) NP-40, 1% (w/v) sodium deoxycholate]. Finally, the beads were washed two times with 1 ml of TE buffer [1 mM EDTA, 10 mM Tris-HCl (pH 8.1)], and antibody-bound chromatin fragments were eluted from the beads by incubation at 65 C for 1 h with elution buffer [1% (w/v) sodium dodecyl sulfate in 0.1 M NaHCO 3 ]. The cross-linking was reversed and the remaining proteins were digested by addition of 40 mg (1.8 U) of proteinase K (Fermentas) and incubation overnight at 65 C. DNA was purified using QIAquick TM PCR purification system (QIAGEN GmbH). ChIP templates were sequenced using Illumina HiSeq System (Illumina) using standard manufacturer protocol at the EMBL Genomics Core Facility (Heidelberg, Germany). For conventional ChIP, quantitative PCR analyses were carried out with LightCycler Õ 480 SYBR Green I Master (Roche Diagnostics GmbH). Specific primers are listed in Supplementary Table S2 . Results were calculated using the formula E À(ÁCt) Â 10, where E (efficiency of target amplification) is a coefficient of DNA amplification by one PCR cycle for a particular primer pair and ÁCt is Ct (ChIPÀtemplate) ÀCt (Input) . Results are presented as fold over the value IgG-precipitated samples. Re-ChIP analyses (in which chromatin was sequentially precipitated with two different antibodies) were performed essentially as previously (27) . 40 bp, and each set was collapsed. The reads were aligned against the human reference genome version hg19 by using Bowtie software version 0.12.9. (34) with the following command line: -e 70 -l 50 -n 1 -k 1 -m 1\-tp 12 -q -S -best. The generated SAM-file were converted to sorted BAM format by SAM tools (35) and subsequently to TDF format for visualization of the data in Integrative Genomics Viewer (IGV) genome browser (36) . The enriched peaks were detected by using MACS program version 1.4.2. (37, 38) , with the following parameters: for GR samples, bandwidth 100, mfold as 10,30 and 1.0 Â 10 À4 as P-value cutoff; for SUMO-2/3 samples, bandwidth 200, mfold as 10,15 and 1.0 Â 10 À4 as P-value cutoff. MACS estimated FDR value by comparing ChIPseq data sets with control data set and vice versa. Subsequently, the peak detection was performed again to estimate the statistical significance of the peaks. Sequenced input from Flp-FRT cell line was used as control file for GR samples, and sequenced control IgG from Flp-FRT cell line was used as control file for SUMO-2/3 samples. Peaks that were selected for further downstream analysis had the following criteria: tags >50, fold enrichment >8, FDR <0.1 and peak had to be present in two biological replicate samples. The GR peaks selected with these criteria had FDR <0.01 in at least one replicate. Additionally, the same peaks were also found with findPeaks command in HOMER software (http://biowhat.ucsd.edu/homer/). Furthermore, the sequenced samples met the ENDOCE ChIP-seq guidelines, e.g. samples had >10 million uniquely mapped reads, the sequence depth of the controls was at the level equal to ChIP samples. Additionally, all the selected peaks had >75% similarity between replicates or >80% of the top 40% of the selected peaks in one biological replicate were also found in the second biological replicate (39, 40) . When identifying overlapping peaks, enrichment on chromosome and annotation (CEAS, version 1.0.0.) analysis and motif analysis (SeqPos, version 1.0.0.; Screen motif, version 1.0.0.; MISP, version 1.0.0.) were performed by Cistrome (41) . Sequence logos where generated by using the R package seqLogo. Association of genes and peaks (GR or SUMO-2/3-enriched binding sites; GRBs or SUMOBs) was done by using GREAT (42) . Kruskal-Wallis one-way analysis of variance was used for comparing the statistical difference in the number of GRBs or that of SUMOBs associated with the dex-regulated genes between the wtGR and the GR3KR cells.
RESULTS
Gene programs regulating cell growth are affected by GR SUMOylation
To study how GR SUMOylation influences gene expression in a genuine chromatin context, we established isogenic HEK293 cell lines stably expressing wtGR or SUMOylation-deficient GR (GR3KR). In the GR3KR, the lysines of the three GR SUMO consensus sites were mutated to arginines, resulting in SUMOylation-deficient GR (11) . Immunoblotting indicated that the HEK293 wtGR and GR3KR cells express comparable levels of the receptor and that the level of endogenous GR in the HEK293 background cells is low, lower than that in A549 lung carcinoma cells (Supplementary Figure S1A) . Compared with the A549 cells, our HEK293 stable cell lines overexpress the GR. Furthermore, immunoblotting of anti-GR-antibody immunoprecipitates with anti-SUMO-1 or anti-SUMO-2/3 antibody confirmed that the wtGR can become modified by endogenous SUMO-2/3, whereas the GR3KR is severely defective, albeit not totally inert, in this respect (Supplementary Figure S1B ) (11) . Next, we compared the gene expression profiles of the wtGR and GR3KR cells that were exposed to dex or vehicle for 6 h by using Illumina HT-12 v4 Expression BeadChips. The analysis indicated that more genes were dex-regulated in the GR3KR cells (675) than in the wtGR cells (451), with 59 and 55% of these genes being upregulated by dex in the wtGR and the GR3KR cells, respectively ( Figure 1A ). All the dex-regulated genes in both cell lines were grouped by unsupervised hierarchical clustering that resulted in eight distinct clusters (clusters 1-8) ( Figure 1B ). Genes that were up-or downregulated by dex only in wtGR cells were clustered to the cluster 2 and the cluster 5, respectively. The clusters 3 and 7 contained genes up-or downregulated by dex only in GR3KR cells, respectively. The cluster 4 contained genes that were dex-regulated in both cell lines, but had a significant difference in their expression between the wtGR and the GR3KR cells. Genes in the clusters 1, the 6 and 8 were dex-regulated in both cell lines and their gene expression did not markedly differ between the cell lines. Most of the genes that were differently dex-regulated between wtGR and GR3KR cells showed both higher overall dex-induced expression level and fold-induction by dex in one cell line compared with the other (Supplementary Figure S2A) . Expression of one gene from each cluster was validated by RT-qPCR analysis (Supplementary Figure S2B) . The 483 genes that were differently expressed between the two cell lines (the clusters 2, 3, 4, 5 and 7) were subjected to IPA to find enriched pathways regulated differently due to GR SUMOylation sites. The top six molecular and cellular functions significantly affected by the GR SUMOylation sites were gene expression, cellular development, growth and proliferation, cell death and survival, cellular movement and cell cycle ( Figure 1C ). We confirmed by RT-qPCR analyses differences in the expression of select dex-upregulated genes that are well-known GR targets associated with the above cellular growth pathways. As shown in Figure 1D , CDKN1C (43) and NFKBIA (7) were dex-regulated in both cell lines, but they had a significantly higher dex-induced expression levels in the wtGR than the GR3KR cells. Conversely, the dex-induced expression level of ELK1 and that of RASD1 were significantly higher in the GR3KR cells. MAFB showed dex-upregulation only the wtGR cells and MERTK only the GR3KR cells. Interestingly, these GR target genes that showed higher expression levels in the wtGR cells have anti-proliferative effects, whereas those that displayed elevated expressions in the GR3KR cells promote cell proliferation. These results imply that LAD1  PRR15L  SOX7  RHOU  CDC42EP4  EGFLAM  ZDHHC14  SLC2A14  GLIS3  BLM  FUT4  JAK1  GCH1  S100A13  C3orf70  ULK1  CDKN1A  ULK1  IRF8  ATP1A1  FHDC1  KCNG1  CRISPLD2  OPRL1  NET1  TSC22D3  ZBTB7C  KBTBD11  FOXO4  B4GALT2  PDZD2  PLAUR  PER1  ZFAND5  MME  ITGB2  C14orf132  NOL3  ELL2  SLC25A4  CTDSPL  FBXO32  FLJ31568  ARNTL  FAM55C  LIPG  TSC22D3  CLN8  GRHL1  C18orf1  C17orf100  TMEM43  ADARB1  C7orf57  SCAND3  ING1  EDNRA  PLAUR  SOX7  C1orf26  ATP1A1  ZNF364  C21orf69  EIF4A3  SLC41A1  FILIP1L  GRHL1  AEN  C9orf61  FOXN4  RGS19  SLC25A18  SEPT4  TSPAN3  FAM134B  PDZD8  CRK  EP400  C20orf177  NRTN  CRK  EDG7  TMEM108  GALNT10  TPM2  MOCOS  FAM62B  STOM  HSPA2  KIAA0232  F3  MERTK  C3orf70  ATP1A1  CMIP  ACSL1  PTTG1IP  ISG20L1  UNC84B  CAMK1G  FLJ31568  KIAA0513  ZDHHC8P  ASB7  ADAMTS8  ADARB1  PLEKHA9  TMEM87A  SBK1  ADARB1  B3GAT1  SLC39A11  SOX18  C16orf80  TSC22D3  OGFRL1  CCDC107  PHLDA1  SLC9A2  RNF115  ENOX2  ZFP36  HPCAL1  TNFRSF10D  SPSB1  BBS1  TMX4  KIAA0355  ABCC8  PRKCQ  WDR60  CRK  GTPBP2  ZBTB16  ZNF57  PTTG1IP  TMEM91  ZDHHC9  STOM  INHBB  OGFRL1  SFXN5  HSPA2  OSBPL5  HSD17B1   KLF10  ALG3  BCOR  NR2F1  KLHL15  TFAP2A  ATF3  IRS4  MEX3B  INSIG1  KLF10  TFAP2A  STC1  JUN  DDIT3  HEY1  POU3F2  HOXA10  SOX2  GAS1  TRIB1  FGF9  MID1IP1  HIST2H2BE  MID1IP1  ZNF503  BRD2  HOXC4  INSIG1  DDX3X  FAM46C  SPEN  C14orf4  HIST2H4A  HEY2  HOXA11  HOXA10  POU3F2  HOXA6  RFESD  NEFL  HIST2H4B  IER3  BCOR  HSPA6   cluster 6   45   genes   CKS2  PIM1  ANKRD50  TRIB3  DLX1  SQLE  GCNT1  HOXD11  FZD8  SQLE  HOXD10  FOXQ1  NGF  TOX3  CDX2  EFNA1  C3orf52  SATB2  SFRP2  TLE4  ADRB2  GUCY1A3  PCDH7  TSHZ1  RGMB  EYA1  HOXA4  CYR61  HOXC6  HOXC9  MID1  GDF15  IGFBP5  ARID5B  SOX2  EGR1  C3orf58  ZIC2  ZIC2  HOXB5  FOXA1  CKS2  PTCHD1  CDH7  DUSP5  HOXC8  HIST1H2BJ  PIM2  BMF  HMOX1  PPP1R15A  TNFRSF12A  SOBP  IDI1  IRF2BP2  PCDH7  TLE4  SCHIP1  NRP1  HOXB8  STC2  MYLIP  DDIT4  BMF  PRAGMIN  SERTAD4  HOXA5  GAS1  NR4A2  FOS  HOXA11AS  HOXA3  RFESD  HEY1  NR2F2  RFESD  IER5  KAL1  BCL11B  BTG1  MID1  AMOT  C10orf140  IGFBP5  RPRM  HOXA13  HOXA9  HMGCS1   cluster 8   88   genes   cluster 4   89   genes   MYC  ANKRD37  HES1  MYC  ARRDC4  ARRDC4  ZNF711  HOXA9  SOX4  RGS16  HSPA1B  BHLHB2  ADAMTS1  HSPA1A  S100P  RASD1  SPRYD5  OKL38  PHACTR3  SLC6A3  PDK4  TUBA3E  TIPARP  TUBA3D  CEBPD  PHACTR3  APOLD1  SGK  C1QTNF1  C10orf10  RP1L1  SGK1  NET1  SGK1  FAM90A7  CDKN1C  LOC729384  OSGIN1  CST1  TUBA3D  LIPG  NFKBIA  FIS  C6orf81  ERN1  MYOM2  S1PR3  ZNF189  ZNF189  CDKN1A  SLC2A3  MB  FAM90A1  TRIM48  ITGB2  CHST3  FAM104A  ASB9  NSDHL  CLN8  KCNA5  ZNF18  ZNF18  PRIC285  KCNG1  CNKSR3  BIRC3  ERN1  KLHL36  TSC22D3  FKBP5  KLF15  NET1  NOL3  SLC25A4  C17orf80  TEX10  KCNG1  ASB9  PHLDA1  SGSM1  PNMT  C1QTNF1  SNN  ELK1  GPER  TUBA3C  FGF18  GPER   cluster 5   38 genes   PTP4A1  PEG10  NFKBIZ  EFNB2  ATXN1  ATP2B1  PROK2  CCND2  ALDH1B1  NPTX2  TRIB2  EPHA4  NCRNA00120  BASP1  CCND2  RNF43  NR3C2  PSG4  KRT17  LBH  RUNX1T1  DNAHL1  PAQR9  PPARD  NOV  KCTD12  WNT5A  CDKN2B  XIST  RAI2  RNF122  KRTAP19-6  TNF  KRTAP19-1  IL8  CCL20  PCDH19  G0S2 cluster 2 SERPINA3  SRGAP3  TBC1D8  RCAN1  SRPK2  MARVELD3  CALB2  KCNJ4  SP110  C17orf58  GADD45G  EGFLAM  LOC440157  SLC31A2  MAP3K6  GPR64  CTDP1  EGFLAM  MAFB  DKFZp451A211  MT1X  SCRG1  RHOB  WNT16  SLC38A11  GPR64  PUS1  SLC7A8  GRASP  RAB33A  TADA2B  PUS1  PRKCE  COMP  PKP2  CDC14A  TSPAN9  SHC4  ERAP2  CASD1  FILIP1L  MAEA  SOCS2  PCSK5  CBLB  SLC1A3  WDR20   cluster 3   154   genes   RAB20  MB  ISG20  ATP4A  HLA-DRA  SHISA2  CSTF3  THSD1  TAOK2  NBN  VPS37A  UPF2  OLFML2B  RAD51C  C16orf5  UPF2  PGC  SSX2IP  MMP28  SELS  RNF14  AGRP  TMEM100  RAD51C  APOL2  NOS2A  APOL2  PHF19  GCOM1  RGS2  HSD11B2  KRCC1  PAQR8  AKTIP  PSD4  MERTK  CDADC1  APOD  IGSF3  MSX2  ZNF688  MRFAP1L1  C18orf54  ACVR1B  B3GAT2  MRFAP1L1  FAM49A  TXLNA  BIRC2  GIPC1  ZNF341  CALD1  ZNF22  PTGES  CAPN7  TF  MAP2K4  RNF14  TRAF5  ACPL2  LOC255167  FBXO21  FAM163A  COL23A1  SNAI2  TRIOBP  DDX24  SLC36A1  SFRS5  WDR7  LINS1  TP53BP2  CHN2  CHN2  NBN  ELMO2  PPP1CB  GOT1  APPL2  NKD1  KLHL26  ACPL2  FBXO32  NMI  NEXN  ASB7  NTF3  FAM65B  ZNF259  MTNR1A  GSTM3  RHPN1  BBS12  HPCAL1  STK35  RASGRP1  CLPTM1L  AP3S1  KCNS3  PPP2R3B  OSBPL11  LPL  GTF2E1  GNA12  ASB7  SLC39A14  ENPP5  B3GAT1  ZNF784  MECP2  SSTR2  TMX4  OSBPL5  RASSF4  PITPNA  XK  PDLIM1  ZSWIM5  FAM105  TPM2  RPS6KA2  ANO6  APPBP2  PLEKHF2  PPP1R3F  SESN1  HMGB3  MN1  ZDHHC9  GCH1  THAP10  FAM100A  GREB1  FZD4  CLEC16A  ALAD  ABHD6  PPP1R1A  ZBTB46  PRKAB2  PPP3CC  SLC44A2  CCDC126  GNA12  ETNK2  C5orf62  PXN  ARCN1  SNX33  CHMP1B  RBMS3  C8orf51  MED30  NAGK   cluster   7   155 genes   USP9X  MNT  IGDCC3  TGIF2  TBX2  ZNF217  KCTD15  CNNM1  BMP6  RSC1A1  SOX21  ARHGAP20  PNMA2  C15orf39  LMO4  SAT1  MICB  FANCB  HCFC1  BTBD3  ZMIZ1  IL12A  CNIH3  TIMM8A  TSPAN12  UNC5B  KLF9  ZNF462  SH2B3  SMG1  SLC7A2  FOXF2  ARHGEF2  FAM43B  FOXC1  HIST1H2AC  HIST1H1C  MEIS1  E2F3  HIVEP1  BHLHB3  MEX3C  UBQLN2  RASEF  PROX1  INHBE  HIST1H4B  C10orf2  ZNF467  DDX26B  TOB1  NRP1  SAMD11  DBP  HCCS  SIX4  FOXD1  TES  IRX5  AVPI1  LDLR  HOXA2  AUTS2  BAMBI  HOXD13  KIAA1804  HIST1H2AG  HIST1H2BD  SMAD6  PRICKLE3  ST8SIA2  TUFT1  SOX12  TET1  LMCD1  C4orf31  ZFX  HOXC13  EXT1  ZNF296  WWP2  GSK3B  FGFR3  GFOD1  RRS1  USP3  MEIS2  LOC729375  PRICKLE1  PDE5A  USP36  LHX6  PLD6  ZNF395  NDE1  SOX8  SGK3  DMRT3  SPRY1  LRRC8E  GAD1  CBX2  PPRC1  NOTCH1  ZFP64  SLAIN1  RASSF1  SVIL  SOBP  HELB  PRDM8  TLCD1  FBXO5  FAM86A  LRRTM4  CXXC4  PI15  SORBS1  NME2  FOXA2  BCORL1  TSC22D1  C19orf23  DMD  CXXC5  LYPD1  HIST1H3B  HRK  LOC645332  CXXC5  TSC22D1  FAM86A  KLF6  KLF6  HSPA1L  SIX1  HIST2H3C  CABLES1  HIST1H2BD  GADD45A  IRF2BP2  DLC1  HIST2H2AA3  CXXC6  CCND1  EFNA1  PMAIP1  PMAIP1  LMO4  GADD45A  ID3 HIST2H3D BCOR HOXA10 HIST2H3A Figure 1 . Glucocorticoid target genes affecting cell growth are differently expressed between wtGR-and GR3KR-expressing HEK293 cells. Cell lines were treated with vehicle or dex for 6 h, RNA was isolated and analyzed by Illumina BeadChips as described in 'Materials and Methods' section. The genes that had P < 0.001 and fold-induction > 1.5 or < 0.7 were considered as dex-regulated genes: 761 genes of 15 784 genes in the array were dexregulated. SUMOylation modulates the GR activity on target genes regulating cellular grow.
genes
To check whether the effect of GR SUMOylation on target gene expression is a feature unique to the HEK293 cells, we next examined the role of GR SUMOylation on gene expression in a different cell model, U2Os cells that have been previously used to study glucocorticoid signaling and post-translational modifications of the GR (10, 13, 44) . We generated U2Os cell lines stably expressing wtGR or GR3KR and analyzed their genome-wide gene expression prolife in the presence and absence of dex. As with the HEK293 cell background, comparison of the dexregulated genes between the U2Os-wtGR and the U2Os-GR3KR cells showed more dex-regulated genes in the SUMOylation-deficient U2Os GR-expressing cells (187 versus 159, respectively) (Supplementary Figure S3A) . The dex-regulated genes in both cell lines were again grouped by unsupervised hierarchical clustering, resulting in six distinct clusters (clusters 1-6) (Supplementary Figure S3B) . One gene from each cluster was validated by RT-qPCR (Supplementary Figure S4) . IPA of the 160 genes that were differently expressed in the two U2Os cell lines revealed essentially the same molecular and cellular functions to be differently dex-regulated by the GR SUMOylation sites as in the HEK293 cells (Supplementary Figure S3C) . RT-qPCR analyses of select dex-regulated genes that were differently expressed between the U2Os-wtGR and the U2Os-GR3KR cells and enriched in the latter cellular functions are shown in Supplementary Figure S3D . As in the HEK293 cells, NFKBIA was dex-regulated in both cell lines, but it had a significantly higher expression in the U2Os-wtGR cells than in the U2Os-GR3KR cells, whereas another wellknown glucocorticoid responsive gene SGK1 (45) showed a significantly higher expression in the U2Os-GR3KR cells than in the U2Os-wtGR cells. IL8 and PMEPA1 were dex-regulated only in the U2Os-wtGR cells and the U2Os-GR3KR cells, respectively. These results indicate that the regulatory effects of GR SUMOylation sites on GR target genes, such as the ones regulating cell growth, are not restricted to only one cell line.
SUMOylation modulates the anti-proliferative effect of dex
Owing to the fact that the wtGR and the GR3KR cells showed significant differences in their dex-regulated expression of genes governing cellular proliferation and survival, we compared their growth rates and cell cycle distributions. As shown in Figure 2A , the GR3KR-expressing HEK293 cells proliferated significantly faster than their wtGR counterpart cells. Interestingly, also the anti-proliferative effect of dex was less pronounced in the GR3KR cells as compared with the wtGR cells; 48 h dex treatment had only a slight anti-proliferative effect on the GR3KR cells, but it markedly retarded the growth of the wtGR cells. The U2Os-GR3KR cells showed a similar trend of enhanced proliferation and attenuated response to dex treatment as the corresponding HEK293 cells (Supplementary Figure S3E) . Additionally, according to FACS analyses, the dex exposure of the wtGR cells, but not that of the GR3KR cells, resulted in a significant decrease in the cells in G 2 /M phase of the cell cycle ( Figure 2B ). Some of dex's anti-proliferative properties are because of its capability to induce apoptosis of certain cell types (46) . Interestingly, dex treatment of the wtGR cells, but not that of the GR3KR cells, leads to a small but a significant increase in the amount of the cells in apo/subG 1 phase of the cell cycle, whereas no such effect was seen in the GR3KR cells. The anti-proliferative effects of dex on the proliferation of wtGR are thus reflected in the increase of cells in the apo/subG 1 and G 1 /G 0 phase as well as the reduction of cells in G 2 /M phase of the cell cycle, whereas in the case of the GR3KR cells, dex only affected the G 1 /G 0 phase. In sum, our results indicate that the GR SUMOylation-associated differences in the The wtGR-and GR3KR-expressing cells were exposed to vehicle or dex for 48 h and the proportion of cells in specific cell cycle phases was analyzed by FACS. ***P < 0.001, **P < 0.01 and *P < 0.05 for the difference between vehicle and dex treatment for indicated cell cycle phase. expression of growth regulatory genes are manifested in the growth of HEK293 cells.
SUMOylation influences genome-wide chromatin occupancy of the GR
To complement the GR target gene expression analyses, we next performed ChIPs with anti-GR antibody from wtGR and GR3KR HEK293 cells exposed to dex and sequenced the precipitated DNAs with Illumina HiSeq (ChIP-seq). The sequence reads of two biological replicates for the both cell lines were aligned to human reference hg19 genome by Bowtie, and MACS software was used to find significantly enriched peaks representing GRBs (cf. 'Materials and Methods' section). The ChIPseq analyses revealed 11 255 and 18 856 high confidence GRBs in the wtGR and the GR3KR HEK293 cells, respectively. The mutation of the GR SUMOylation sites resulted in 8854 additional GRBs, whereas 1253 GRBs were lost and 10 002 GRBs remained unchanged ( Figure 3A) . However, the same classic GRE was found as the most enriched motif both in the wtGR unique and the GR3KR unique as well as the wtGR and GR3KR shared sites, when 1000 best-scoring GRBs for each group were analyzed ( Figure 3C ). At least one classic GRE was found in $84 and 71% of the wtGR and GR3KR GRBs, respectively. In addition to the GREs, helix-loop-helix (HIF1A)-and E-twenty six (ETS) domain-binding motifs were found to be enriched in the GRBs unique to the GR3KR, and the shared GRBs additionally harbored homeodomain (SHOX2)-binding motifs. Interestingly, merely GREs were found in the wtGR unique GRBs. The overall distribution of the GRBs in relation to gene structures was practically the same in the wtGR and the GR3KR cells; most of the GRBs resided in introns or were intergenic ( Figure 3B ). In both cases, only $10% of the GRBs were found within promoter regions (up to 10 kb upstream from transcription start sites, TSSs) and $6% within 10 kb downstream from the gene. Of the genes whose expression was associated with dex regulation, i.e. altered by dex exposure, 58% in the wtGR cells and 69% the GR3KR cells showed at least one GRB ± 100 kb from their TSS. More upregulated genes than downregulated genes were associated with at least one GRB (Supplementary Figure  S5A and B). The majority ($63%) of the GRBs associated with the dex-upregulated genes were shared between the wtGR and the GR3KR (Figure 3D ), whereas the proportion of the shared GRBs was lower ($44%) among the dex-repressed genes ( Figure 3E ). Most of the GRBs associated with the dex-downregulated genes were intergenic, not intronic as in the case of the upregulated GR targets (Figure 3D and E). On average, there were more GRBs associated per one dex-up-and downregulated locus in the GR3KR cells compared with the wtGR cells, respectively. The difference in the number of the GRBs associated with the dex-upregulated genes between the wtGR and the GR3KR cells was significant (P < 0.05). Unique and shared GRBs of the dexupregulated genes displayed at least one GRE per GRB, respectively, whereas in contrast to the wtGR unique GRBs of dex-repressed genes that showed no enrichment of full GREs, but only half GRE sites, the GR3KR unique GRBs displayed full GREs at a ratio of 1.8 GREs/GRB and enrichment of ETS domain-binding motifs ( Figure 3G ). The latter motif was also identified in the GR3KR unique GRBs, but not in the wtGR unique GRBs, of dex-activated genes ( Figure 3F) . Interestingly, no AP-1 -or NF-kB-binding motifs were found to be enriched in the GRBs associated with the dex-repressed genes in the wtGR or the GR3KR cells.
Of the genes differently up-or downregulated by glucocorticoid because of the GR SUMOylation sites (i.e. genes that were dex-regulated in both cell lines but had a significant difference in their expression due to the GR SUMOylation sites), however, only a small number showed a GRB exclusively either in the wtGR cells (7 genes) or the GR3KR cells (86 genes) (Supplementary Figure S5E and F) . Only one of the seven genes with the wtGR cell unique GRBs, the CDKN1C, was upregulated by dex, whereas the rest of them, HOXC13, TSC22D1, CCND2, HOXA9, IL8 and ZIC2, were downregulated, with the repression of the latter four genes being significant only in the wtGR cells (Supplementary Figure S5E and F). Similarly, the majority (55/86) of the genes with the GR3KR unique GRBs were downregulated by dex with the majority of them being significantly downregulated only in the SUMOylation mutant GR cells (Supplementary Figure S5E and F) .
Occupancy of SUMO-2/3 on the chromatin differs between the wtGR-and the GR3KR-expressing cells
We have recently shown evidence for co-occupancy of AR (highly related to the GR) and SUMO-2/3 on the chromatin of prostate cancer cells (27) . Because SUMO-2 is the most abundant SUMO isoform in the HEK293 cells (data not shown) and the GR can be modified by SUMO-2/3 (Supplementary Figure S1B) , we next performed ChIP-seq analyses with anti-SUMO-2/3 antibody from the wtGRand the GR3KR-expressing HEK293 cells exposed to dex. The sequence reads of two biological replicates were analyzed in the same way as the GR data to find out whether there are significantly enriched peaks representing SUMO-2/3-enriched binding sites (SUMOBs). Interestingly, these genome-wide analyses revealed that SUMO-2/3 is enriched at 12 109 and 7753 high confidence SUMOBs in the wtGR and the GR3KR cells, respectively. Mutation of the GR SUMOylation sites associated with a loss of 6329 SUMOBs and an appearance of 1973 new SUMOBs, whereas 5780 SUMOBs remained unchanged ( Figure 4A) . Comparison of the overlap between the GRBs and the SUMOBs showed $38% co-occupancy in the wtGR cells ( Figure 5A ) and $16% co-occupancy in the GR3KR cells ( Figure 5B ). The GRE was found in the SUMOBs unique to the wtGR as well as in the SUMOBs shared between the wtGR and the GR3KR, but only a homeodomain (PAX6)-binding motif was found in the SUMOBs unique to the GR3KR, when 1000 bestscoring SUMOBs for each group were analyzed ( Figure 4C ). In addition to the classic GRE, the SUMOBs unique to the wtGR showed enrichment of Figure 3 . Genome-wide occupancy of the GR in chromatin is influenced by the receptor's SUMOylation sites. The wtGR-and GR3KR-expressing HEK293 cells were exposed for dex for 1 h, and ChIP-seq of anti-GR antibody-precipitated samples was performed using Illumina HiSeq System as described in 'Materials and Methods' section. Obtained sequence reads were aligned to human reference genome by using Bowtie and significantly enriched peaks that represent GRBs were detected using MACS as described in 'Materials and Methods' section. Figure 4B ) and similar to that of the GRBs. However, clearly more SUMOBs than the GRBs, $21 versus 10%, were found at the promoter regions (cf. Figure 3B versus Figure 4B ).
Of the genes whose expression was altered by dex, 55% in the wtGR cells and 47% in the GR3KR cells showed at least one SUMOB ± 100 kb from their TSS. More upregulated genes than downregulated genes were associated with at least one SUMOB (Supplementary Figure S6A and B) . Over half of the GRBs associated with the dex-upregulated genes in the wtGR cells overlapped with the SUMOBs (Figure 5C ), whereas less than one-third in the GR3KR did so ( Figure 5D ). For the dex-downregulated genes, the co-occupancy percentages were generally lower ( Figure 5E and F) . On average, there were more SUMOBs associated per one dex-upand downregulated locus in the wtGR cells compared with the GR3KR cells, respectively. The difference in the number of the SUMOBs associated with the dexupregulated genes between the wtGR and the GR3KR cells was significant (P < 0.05). Also, when related to the number of GRBs per dexregulated locus, there were on average more SUMOBs in the wtGR than in the GR3KR cells ( Figure 4D and E). As with the GRBs, only a small number of genes showed a SUMOB exclusively in the wtGR cells (83 genes) or the GR3KR cells (28 genes) (Supplementary Figure S6E and F) . The GRE and a leucine zipper (JUND)-binding motif were found to be enriched merely among the wtGR unique SUMOBs, whereas an NR2-type nuclear receptor motif was enriched at the wtGR and the GR3KR shared SUMOBs, and no motif was enriched at the GR3KR unique SUMOBs associated with the dex-up-regulated loci ( Figure 4F) . Interestingly, the GRE was not enriched among the SUMOBs associated with dexdownregulated loci ( Figure 4G) .
Comparison of the GRBs and the SUMOBs associated with dex-regulated genes between the wtGR and the GR3KR cells also indicated that the majority ($77%) of the sites that contain both the GRBs and the SUMOBs in the wtGR cells, but merely the GRBs in the GR3KR cells, are associated with genes that are differently regulated between these cells, such as NFKBIA, RASD1 and MAFB ( Figure 5G and H) . Moreover, most of the unique or the shared GRBs in the wtGR and the GR3KR cells without SUMOBs were differently dex-regulated between these cells. Interestingly, the ETSdomain motif was found to be enriched at the GR3KR unique GRBs without SUMOBs (Supplementary Figure  S7A and B).
GR occupancy in loci regulating cellular growth is sensitive to SUMOylation
Although on the whole genome level, the majority of the GRBs were insensitive to the GR SUMOylation sites, inspection of the ChIP-seq data revealed reproducible and clear differences between the wtGR and the GR3KR chromatin occupancy of genes linked to cellular growth and survival pathways. For example, the differences in the GR occupancy of the growth regulatory genes analyzed in Figure 1D paralleled with their gene expression levels. At the CDKN1C locus ( Figure 6A ), there was a significant GRB $5 kb upstream from the TSS only in the wtGR cells. At the NFKBIA locus ( Figure 6B ), the enrichment of GR in the GRBs closest to the NFKBIA was clearly higher in the wtGR cells. The situation was similar at the MAFB locus ( Figure 6F ). The intronic sites of ELK1 ( Figure 6C ) contained two GRBs in the GR3KR cells but only one in the wtGR cells that had a lower GR occupancy than its counterpart in the GR3KR cells. Similarly, the GR occupancy at the MERTK locus and that at the RASD1 were higher in the GR3KR cell locus ( Figure 6D and E) . Interestingly, the binding of SUMO-2/3 to the NFKBIA, the ELK1, the RASD1 and the MAFB overlapped with that of wtGR, whereas only the strongest GRBs in the NFKBIA, ELK1 and MAFB loci showed binding of both SUMO-2/3 and GR3KR, and the SUMO-2/3 binding to these sites was clearly weaker than with the wtGR. Re-ChIP assays in which chromatin was sequentially immunoprecipitated with anti-SUMO-2/3 and anti-GR antibody confirmed the simultaneous presence of the SUMO-2/3 and the GR at the two RASD1 regulatory regions (cf. Figure 6E ) and at the one MAFB regulatory region (cf. Figure 6F ) in the wtGR cells but not in the GR3KR cells (Figure 7) . These results strongly suggest that chromatin-bound GR can be conjugated by SUMO-2/3. The GR chromatin occupancy of dex-repressed genes was also sensitive to GR SUMOylation. Examples of the GR chromatin occupancy in the loci whose expression was differentially dexrepressed between the wtGR and the GR3KR cells (Supplementary Figure S8) are shown in Figure 8 . For example, CXXC4, DMRT3 and SPRY1 displayed higher chromatin occupancy by GR3KR than wtGR, which also paralleled with the differential ability of these two receptor The genome-wide occurrence of SUMO-2/3 chromatin marks differs between the wtGR-and GR3KR-expressing cells. The wtGR-and GR3KR-expressing HEK293 cells were exposed for dex for 1 h, and ChIP-seq of anti-SUMO-2/3 antibody-precipitated samples was performed using Illumina HiSeq System as described in 'Materials and Methods' section. Obtained sequence reads were aligned to human reference genome by using Bowtie and significantly enriched peaks that represent SUMO-2/3-binding sites (SUMOBs) were detected using MACS cf. 'Materials and Methods' section. forms to repress these genes. In the case of CCND2, IL8 and ZIC2, the situation was converse, but with regard to the GR occupancy, the differences were less dramatic. However, the SUMO-2/3 binding to these loci was generally low in comparison with the examples of dexupregulated genes sensitive to GR SUMOylation.
DISCUSSION
SUMOylation has emerged as an important regulatory modification of transcription factors, including nuclear receptors (47). SUMOylations have been often linked to transcriptional repression (15, 48) . However, the effects of SUMO modifications on transcription factor function and targets have only in rare cases been addressed in a systematic genome-wide fashion. In this work, we have used genome-wide approaches to investigate how SUMOylation sites of the GR influence endogenous target gene expression and GR chromatin occupancy by using isogenic HEK293 cell models expressing either the wtGR or the SUMOylation-defective GR. Analysis of genes differentially regulated by the wtGR and the GR SUMOylation mutant indicated that the SUMOylation sites do not simply repress the GR activity on all target genes; the mutant exhibited differential, also attenuated transcriptional activity, but not on all the target genes. SUMOylation not merely affected the expression of dexinduced genes, but it also influenced the ability of GR to repress its target genes. Interestingly, IPA revealed that the differently expressed genes were significantly associated with molecular and cellular functions of gene expression, development, movement, growth and proliferation, cell death and survival and cell cycle. Many genes, such as CDKN1C and NFKBIA, that have anti-proliferative effects showed significantly stronger dex-upregulation by the wtGR. The CDKN1C encodes a cyclin-dependent kinase inhibitor p57 that inhibits cell proliferation by accumulating cells in the G 1 phase of the cell cycle (43, 49, 50) . The NFKBIA has an anti-proliferative effect due to its protein product IkBa's ability of restrict the action of NF-kB (6, 8) . On the other hand, genes, such as ELK1 and RASD1, that were more robustly upregulated by the SUMOylation-deficient GR are associated with promotion of cell proliferation. ELK1 is an ETS transcription factor family member and regulated by the RAS-RAF-MAPK signaling. It interacts with the serum response factor and the serum response element in the c-FOS promoter (51, 52) . The RASD1, a member of the RAS superfamily, may play a role in dex-induced alterations in cell morphology, growth and cell-extracellular matrix interactions (53) . The GR SUMOylation sites affected essentially the same molecular and cellular programs in our other cell model, U2Os cells as in the HEK293 cells. The NFKBIA was expressed at a significantly higher level in also dexexposed wtGR-expressing U2Os cells. As expected, there were also cell-specific differences in the expression of certain target genes, such as IL8, a proinflammatory chemokine (54) that was upregulated in the wtGR U2Os cells, but unaffected by dex in the GR3KR U2Os cells, whereas in the corresponding HEK293 cell model, the gene was significantly downregulated by dex, but only in the wtGR cells. On the other hand, PMEPA1, that has been shown to confer cell growth inhibition in AR positive prostate cancer cells (55) , was dex-downregulated only in GR3KR U2Os cells.
SUMOylation also influenced the GR cistrome. On the whole genome-wide level, the mutation of the GR SUMOylation sites yielded seven times more GRBs than were lost, albeit the majority of them were not affected by the mutation. However, the genomic location distribution of the GRBs remained essentially unaffected by the mutation of GR SUMOylation sites. In the both cell models, more than half ($52%) of the GRBs resided in introns, whereas promoter regions (up to 10 kb upstream from TSSs) harbored only $10% of the GRBs. These genomic distribution figures are similar to those of the GRBs recently reported from HeLa B2 cells, mouse primary bone marrow-derived macrophages and mouse mammary 3134 adenocarcinoma cells (56) (57) (58) . The classical GRE that was also identified in these ChIP-seq analyses (56) (57) (58) (59) was the prevalent motif found in our model HEK293 cells.
The dex-upregulated genes in both cell models contained more commonly at least one GRB than the downregulated genes (the wtGR cells: 73 versus 43%; the GR3KR cells: 79 versus 58%, respectively), suggesting that the dex-induced gene activation is more commonly associated to direct binding of holo-GR to the target locus than the gene repression. Also the average numbers of GRBs per dex-regulated locus were higher for the dex-activated genes than for the dex-repressed genes, with the numbers being 2.7 versus 1.7 for the wtGR and 3.5 versus 2.2 for the GR3KR, respectively. However, comparison of motif signatures within gene 0 from TSS) regulatory regions after 1 h exposure to dex were monitored using qChIP with anti-GR antibody (left panel). Results are shown as fold over to the normal IgG-precipitated samples. (Right panels) The same chromatin regions were analyzed by re-ChIP assays in which chromatin was sequentially immunoprecipitated with anti-SUMO-2/3 and anti-GR antibody. Results are shown as fold over to control re-ChIP assays in which normal IgG was used instead of the anti-GR antibody. Blue bars depict dex-treated wtGR-expressing cells and red bars dex-treated GR3KR-expressing cells and results represent the mean ± SD of three experiments. ***P < 0.001; **P < 0.01 and *P < 0.05 (Student's t-test) for the difference of vehicle and dex treatment in either wtGR-or GR3KR-expressing cells or for the difference of dex treatment between wtGR-and GR3KR -expressing cells. ns, no significance. repression-and activation-associated GRBs revealed remarkably similar features and the presence of GREs in both cases, which was recently also noted by Uhlenhaut and co-workers (57) , suggesting that the GR binding to GREs commonly mediates the gene repression. This notion contrasts with previous ideas based on a relatively small number of model target gene promoters, that mainly tethering of GR to AP-1 or NF-kB is responsible for the repression of transcription by glucocorticoids (6) . Interestingly, most of the GR SUMOylation-modulated GRBs were associated with genes that were downregulated by dex.
It is of note, however, that of the all dex-regulated loci associated with at least one GRB within 100 up-or downstream the gene (462 loci), only a minor portion was exclusively occupied by the wtGR (7 loci) or the SUMOylation-deficient GR (86 loci). More typically than having unique GRBs, GR target loci differentially regulated because of the GR SUMOylation sites, such as the NFKBIA, the ELK1 and the RASD1, associated with cell proliferation, showed differences in their number of GRBs and/or in the level of GRB receptor occupancy between the wtGR and the GR3KR cells. Generally, the level of receptor occupancy in a given locus correlated with the glucocorticoid-responsiveness of gene expression of the locus. This was seen both in the case of gene induction and repression. The cells expressing SUMOylation mutant GR proliferated more rapidly and their antiproliferative response to dex was less pronounced than in the wtGR-expressing cells. The difference was associated with the altered regulation and GR chromatin occupancy of several genes influencing cell growth. Interestingly, also in the case of progesterone receptor (PR), SUMOylation was recently reported to regulate PR target gene selection in breast cancer cells, and again the SUMO sensitive PR target genes included genes required for proliferative and pro-survival signaling, which was reflected in the growth of these cells (60) . Indirect effects caused by the long-term expression of different forms of PR and GR may to a small extent have differently programed the cells, which may have also contributed to their growth characteristics. Similarly, SUMOylation-defective microphthalmia-associated transcription factor (MITF) mutant that is associated to predisposition to melanoma and renal carcinoma clearly differed from its wild-type counterpart on some, but not all, MITF target genes, with the subset of genes affected being related to cell growth and proliferation (61) . As with the GR, the SUMOylation site mutation influenced the MITF's chromatin occupancy (61) . Mutation of the SUMOylation sites in GATA-1 in turn considerably attenuated its capability to induce several genes controlling hematopoiesis, and the attenuated activity was linked to decreased chromatin occupancy (62) . Moreover, elimination of orphan nuclear receptor SF-1 (steroidogenic factor 1) SUMOylation in mice resulted in abnormal Hedgehog signaling and endocrine development (63) . The abnormalities seemed to be linked to altered recognition of a group of target genes sensitive to the modification of SF-1 (63) . These results together indicate that SUMOylation can regulate target gene selection of sequence-specific transcription factors, at least in part by influencing chromatin occupancy of transcription factors.
Our ChIP-seq data also revealed the occurrence of SUMO-2/3 in the chromatin and its enrichment to gene regulatory regions. Overall, the chromatin distribution of SUMO-2/3 peaks in the GR-expressing HEK293 cells resembled that of the GRs peaks, with the majority of the peaks being at intergenic or intronic regions. The occurrence of SUMO-2/3 in the promoter regions, however, was more prominent than that of GR. Comparison of the overlap between the GR binding and the SUMO-2/3 marks showed a markedly better (2-fold higher) overlap in the SUMOylation competent GR than in the modification deficient GR-expressing cells. This difference and results from sequential ChIP assays imply that SUMOylated GR is capable of interacting with the chromatin. Furthermore, the GRE was found to be enriched merely among the wtGR cell unique SUMO-2/3-binding sites of the dex-regulated loci, whereas no sequence motif enriched at the GR3KR unique SUMO-2/3-binding sites. However, because the SUMO-2/3 was still found to cooccupy a large number of sites with the SUMOylation deficient GR, the chromatin co-occupancy does not solely derive from the SUMOylated GR, but also from other chromatin-interacting proteins, transcription factors or coregulators, that can be modified by SUMOs. The occurrence of chromatin SUMO-2/3 marks in relation to the GR-binding enhancers and the promoters of dex-regulated genes in our model HEK293 cells compared with the cell background (without added GR, data not shown) indicates that the chromatin-bound SUMO-2/3 is associated with transcriptionally active chromatin and playing a dynamic role in the modulation of GR function on the chromatin. Additionally, comparison of the ENCODE DNase-seq data set from HEK293T cells with our data sets indicates !30 and 45% overlap with the SUMO-2/3+GR peaks and the SUMO-2/3 À GR peaks, respectively, with the DNaseI hypersensitive chromatin sites, i.e. 'open' chromatin regions (Supplementary Figure S11) . The ENCODE HEK293 cell H3K4me3 data set showed also !30% overlap with the SUMO-2/3 À GR peaks, whereas the overlap with the SUMO-2/3+GR peaks was <10%, possibly reflecting the differential enrichment of the histone mark and the GR at promoter regions (Supplementary Figure S11) . While this article was under review, a genome-wide study from WI38 human fibroblast revealed that SUMO-2/3 and SUMOylation machinery are enriched at the histone and transfer RNA gene clusters (64) . Interestingly, this enrichment is not restricted to the fibroblasts, as a similar SUMO-2/3 enrichment is visible at the same gene clusters in our HEK293 model cells (data not shown). Otherwise, however, less than one-third of the SUMO-2/ 3 peaks in the wtGR HEK293 cells (32% in vehicle-and 30% dex-exposed cells) overlap with those in the WI38 cells. Interestingly, binding motif analyses of the GRBs indicated, in addition to the GREs, enrichment ETS domain-binding motifs among the GR3KR unique GRBs associated with dex-up-and dex-downregulated genes. Unfortunately, the in silico analyses cannot differentiate between the ETS family proteins and able to predict the most likely binding candidate, as the DNAbinding specificities of the family members are highly similar (65) . The motif analyses suggest that SUMOylation may influence the GR chromatin occupancy and target gene selection via regulating interactions with other sequence-specific transcription factors, such as ETS proteins, which may promote or prevent the GR binding to the chromatin. The average number of GREs among the GRBs that were unique to the SUMOylation mutant GR was also somewhat higher than that among the wtGR unique GRBs. Inspection of the GRBs associated with the dex-repressed genes revealed enrichment of full GREs (1.8 GREs/GRB) among the GR3KR unique GRBs, whereas only half sites of GREs were present among the wtGR unique GRBs. Thus, our results also hint at the possibility that GRB signature, or number of GRE within the binding sites, contributes to the SUMOylation-regulated binding of GR to its DNA targets. This notion is reminiscent of the synergy control motif concept in which SUMOylation-mediated regulation of GR's synergistic activity depends on stable interaction with DNA (29) . SUMOylation-mediated synergy control may also involve local changes in histone marks and chromatin signature (66) . In conclusion, our objective genome-wide analyses reveal that SUMOylation does not simply repress the GR activity, but the modification regulates the receptor's target gene selection and it plays an important role in controlling the anti-proliferative effect of glucocorticoids.
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